Skip to main content
PMC home page
California Medicine logoLink to California Medicine
. 1964 Sep;101(3):191–195.

Aldosterone in Clinical Medicine

Edward G Biglieri, Paul E Slaton Jr
PMCID: PMC1515587  PMID: 14204551

Full text

PDF
191

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AUGUST J. T., NELSON D. H., THORN G. W. Response of normal subjects to large amounts of aldosterone. J Clin Invest. 1958 Nov;37(11):1549–1555. doi: 10.1172/JCI103747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BARBER J. K., BARTTER F. C., DELEA C., DUNCAN L. E., Jr, LIDDLE G. W. The regulation of aldosterone secretion in man: the role of fluid volume. J Clin Invest. 1956 Nov;35(11):1306–1315. doi: 10.1172/JCI103386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BARTTER F. C., DUNCAN L. E., Jr, LIDDLE G. W. Dual mechanism regulating adrenocortical function in man. Am J Med. 1956 Sep;21(3):380–386. doi: 10.1016/0002-9343(56)90038-9. [DOI] [PubMed] [Google Scholar]
  4. BARTTER F. C. The role of aldosterone in normal homeostasis and in certain disease states. Metabolism. 1956 Jul;5(4):369–383. [PubMed] [Google Scholar]
  5. BIGLIERI E. G., HANE S., SLATON P. E., Jr, FORSHAM P. H. In vivo and in vitro studies of adrenal secretions in Cushing's syndrome and primary aldosteronism. J Clin Invest. 1963 Apr;42:516–524. doi: 10.1172/JCI104740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. BIGLIERI E. G., SLATON P. E., Jr, FORSHAM P. H. Useful parameters in the diagnosis of primary aldosteronism. JAMA. 1961 Oct 7;178:19–22. doi: 10.1001/jama.1961.03040400021004. [DOI] [PubMed] [Google Scholar]
  7. CHOBANIAN A. V., BURROWS B. A., HOLLANDER W. Body fluid and electrolyte composition in arterial hypertension. II. Studies in mineralocorticoid hypertension. J Clin Invest. 1961 Feb;40:416–422. doi: 10.1172/JCI104269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. CONN J. W. Aldosteronism and hypertension. Primary aldosteronism versus hypertensive disease with secondary aldosteronism. Arch Intern Med. 1961 Jun;107:813–828. doi: 10.1001/archinte.1961.03620060013005. [DOI] [PubMed] [Google Scholar]
  9. CRANE M. G., HARRIS J. J., HOLLOWAY J. E. Exchangeable sodium and potassium in primary aldosteronism. J Lab Clin Med. 1963 Jan;61:51–66. [PubMed] [Google Scholar]
  10. FLOOD C., LAYNE D. S., RAMCHARAN S., ROSSIPAL E., TAIT J. F., TAIT S. A. An investigation of the urinary metabolites and secretion rates of aldosterone and cortisol in man and a description of methods for their measurement. Acta Endocrinol (Copenh) 1961 Feb;36:237–264. doi: 10.1530/acta.0.0360237. [DOI] [PubMed] [Google Scholar]
  11. GENEST J., KOIW E., NOWACZYNSKI W., LEBOEUF G. Further studies on urinary aldosterone in human arterial hypertension. Proc Soc Exp Biol Med. 1958 Mar;97(3):676–679. doi: 10.3181/00379727-97-23843. [DOI] [PubMed] [Google Scholar]
  12. GIROUD C. J., STACHENKO J., VENNING E. H. Secretion of aldosterone by the zona glomerulosa of rat adrenal glands incubated in vitro. Proc Soc Exp Biol Med. 1956 May;92(1):154–158. doi: 10.3181/00379727-92-22416. [DOI] [PubMed] [Google Scholar]
  13. HICKLER R. B., THOMPSON G. R., FOX L. M., HAMLIN J. T., 3rd Successful treatment of orthostatic hypotension with 9-alpha-fluorohydrocortisone. N Engl J Med. 1959 Oct 15;261:788–791. doi: 10.1056/NEJM195910152611604. [DOI] [PubMed] [Google Scholar]
  14. KAPLAN N. M. PRIMARY ALDOSTERONISM WITH MALIGNANT HYPERTENSION. N Engl J Med. 1963 Dec 12;269:1282–1286. doi: 10.1056/NEJM196312122692403. [DOI] [PubMed] [Google Scholar]
  15. LARAGH J. H., ANGERS M., KELLY W. G., LIEBERMAN S. Hypotensive agents and pressor substances. The effect of epinephrine, norepinephrine, angiotensin II, and others on the secretory rate of aldosterone in man. JAMA. 1960 Sep 17;174:234–240. doi: 10.1001/jama.1960.03030030014003. [DOI] [PubMed] [Google Scholar]
  16. LARAGH J. H., STOERK H. C. A study of the mechanism of secretion of the sodium-retaining hormone (aldosterone). J Clin Invest. 1957 Mar;36(3):383–392. doi: 10.1172/JCI103434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. LARAGH J. H. The role of aldosterone in man. Evidence for regulation of electrolyte balance and arterial pressure by a renal-adrenal system which may be involved in malignant hypertension. JAMA. 1960 Sep 17;174:293–295. doi: 10.1001/jama.1960.63030030007014. [DOI] [PubMed] [Google Scholar]
  18. LARAGH J. H., ULICK S., JANUSZEWICZ V., DEMING Q. B., KELLY W. G., LIEBERMAN S. Aldosterone secretion and primary and malignant hypertension. J Clin Invest. 1960 Jul;39:1091–1106. doi: 10.1172/JCI104124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. LUETSCHER J. A., Jr, JOHNSON B. B. Observations on the sodium-retaining corticoid (aldosterone) in the urine of children and adults in relation to sodium balance and edema. J Clin Invest. 1954 Nov;33(11):1441–1446. doi: 10.1172/JCI103022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. LUETSCHER J. A., Jr, NEHER R., WETTSTEIN A. Isolation of crystalline aldosterone from the urine of a nephrotic patient. Experientia. 1954 Nov 15;10(11):456–458. doi: 10.1007/BF02170397. [DOI] [PubMed] [Google Scholar]
  21. SIMPSON S. A., TAIT J. F., WETTSTEIN A., NEHER R., VON EUW J., REICHSTEIN T. Isolierung eines neuen kristallisierten Hormons aus Nebennieren mit besonders hoher Wirksamkeit auf den Mineralstoffwechsel. Experientia. 1953 Sep;9(9):333–335. doi: 10.1007/BF02155834. [DOI] [PubMed] [Google Scholar]
  22. SIMPSON S. A., TAIT J. F., WETTSTEIN A., NEHER R., VON EUW J., SCHINDLER O., REICHSTEIN T. Konstitution des Aldosterons, des neuen Mineralocorticoids. Experientia. 1954 Mar 15;10(3):132–133. doi: 10.1007/BF02158515. [DOI] [PubMed] [Google Scholar]
  23. ULICK S., LARAGH J. H., LIEBERMAN S. The isolation of a urinary metabolite of aldosterone and its use to measure the rate of secretion of aldosterone by the adrenal cortex of man. Trans Assoc Am Physicians. 1958;71:225–235. [PubMed] [Google Scholar]
  24. WALSER M., DUFFY B. J., Jr, GRIFFITH H. W. Body fluids in hypertension and mild heart failure. J Am Med Assoc. 1956 Mar 10;160(10):858–864. doi: 10.1001/jama.1956.02960450040010. [DOI] [PubMed] [Google Scholar]
  25. WRONG O. Incidence of hypokalaemia in severe hypertension. Br Med J. 1961 Aug 12;2(5249):419–421. doi: 10.1136/bmj.2.5249.419. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from California Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES